← Back to guidelines
Urology56 papers

Medullary sponge kidney without nephrocalcinosis

Last edited: 4/10/2026

Overview

Medullary sponge kidney (MSK) is a congenital renal anomaly characterized by cystic dilatation of the medullary and papillary portions of the collecting ducts. While often asymptomatic, it can be associated with complications such as nephrolithiasis, urinary tract infections, and renal tubular acidosis. This summary focuses on MSK specifically in the absence of nephrocalcinosis.

Diagnosis

  • Diagnosis is typically made via imaging studies, with intravenous urography (IVU) or contrast-enhanced computed tomography (CT) demonstrating characteristic ectasia of the collecting ducts 1.
  • Nephrocalcinosis, the presence of calcium deposits within the renal parenchyma, is a distinct finding that is not* present in the context discussed here.

    Management

  • Asymptomatic patients without complications generally do not require specific treatment.
  • Management focuses on addressing complications such as nephrolithiasis, urinary tract infections, or metabolic derangements 1.
  • For nephrolithiasis, treatment options may include percutaneous nephrolithotomy (PCNL) 234 or other stone removal techniques. Laser lithotripsy has shown high stone-free rates and relatively low complication rates in PCNL 3.
  • Postoperative care after PCNL may involve different strategies for managing the nephrostomy tract, including tubeless or totally tubeless approaches, which may affect patient outcomes 2.
  • Specialized cushions have been investigated to improve patient comfort and reduce complications like renal hemorrhage and pressure ulcers after PCNL 4.
  • Key Recommendations

  • Percutaneous nephrolithotomy (PCNL) is a standard treatment for large kidney stones, with various techniques including laser lithotripsy demonstrating efficacy and acceptable complication rates 23. (Evidence: Moderate)
  • Postoperative positioning aids may improve patient comfort and reduce complications following PCNL 4. (Evidence: Moderate)
  • Management strategies for the percutaneous tract after PCNL vary, with tubeless and totally tubeless options being compared to standard nephrostomy tube placement 2. (Evidence: Moderate)
  • References

    1 Waldbillig F, von Rohr L, Nientiedt M, Neuberger M, Wessels F, V Hardenberg J et al.. Prospective, Randomized Comparative Evaluation of a Novel Hands-On Endourology Training Curriculum. Urologia internationalis 2023. link 2 Wilhelm K, Hein S, Kunath F, Schoenthaler M, Schmidt S. Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones. The Cochrane database of systematic reviews 2023. link 3 Rice P, Somani BK. Percutaneous laser nephrolithotripsy: is it here to stay? Results of a systematic review. Current opinion in urology 2022. link 4 Xue J, Yang Q. Clinical application of a special postoperative position cushion for patients after percutaneous nephrolithotomy: a randomized trial. Annals of palliative medicine 2021. link

    Original source

    1. [1]
      Prospective, Randomized Comparative Evaluation of a Novel Hands-On Endourology Training Curriculum.Waldbillig F, von Rohr L, Nientiedt M, Neuberger M, Wessels F, V Hardenberg J et al. Urologia internationalis (2023)
    2. [2]
      Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones.Wilhelm K, Hein S, Kunath F, Schoenthaler M, Schmidt S The Cochrane database of systematic reviews (2023)
    3. [3]
    4. [4]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG